Literature DB >> 31264364

Probing 2H-Indazoles as Templates for SGK1, Tie2, and SRC Kinase Inhibitors.

Jens Schoene1, Thais Gazzi1, Peter Lindemann1, Mathias Christmann2, Andrea Volkamer3, Marc Nazaré1,4.   

Abstract

The broader and systematic application of a novel scaffold is often hampered by the unavailability of a short and reliable synthetic access. We investigated a new strategy for the design and synthesis of an array of N2-substituted aza-2H-indazole derivatives as potential kinase inhibitors. Guided by a rational ligand alignment approach to qualify the so-far underrepresented aza-2H-indazole scaffold, indazoles were connected at the N2 position with a phenyl spacer and an arylsulfonamide or amide linkage. Initial profiling against a panel of 30 kinases confirmed the in silico predicted selectivity bias. A synthesized focused library of 52 different aza-2H-indazole derivatives showed good initial selective inhibition against SGK1, Tie2, and SRC kinases, with the best representatives having IC50 values in the range of 500 nm. In a comparative computational study, these data were analyzed and rationalized in light of docking studies.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  docking; drug design; focused library; kinase inhibition; nitrogen heterocycles; scaffolds

Year:  2019        PMID: 31264364     DOI: 10.1002/cmdc.201900328

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  2 in total

Review 1.  Current progress, challenges and future prospects of indazoles as protein kinase inhibitors for the treatment of cancer.

Authors:  Nitin Tandon; Vijay Luxami; Divya Kant; Runjhun Tandon; Kamaldeep Paul
Journal:  RSC Adv       Date:  2021-07-20       Impact factor: 4.036

2.  Synthesis of indazoles from 2-formylphenylboronic acids.

Authors:  Vitalii V Solomin; Alberts Seins; Aigars Jirgensons
Journal:  RSC Adv       Date:  2021-06-28       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.